semaglutide vs zepbound Tirzepatide: Head-to-Head for Weight Loss & Diabetes Semaglutide vs Tirzepatide: Which GLP-1

Daily administration of LY2405319 to type 2 diabetes patients for 4 weeks significantly reduced triglycerides by about 45% and LDL-cholesterol by 2030% from baseline, while increasing HDL-cholesterol by 1520% and adiponectin by up to 80% (244)

14,15 Because of the results of these landmark clinical trials, evidence-based treatment guidelines now recommend the GLP-1/GIP agonists as an important second-line treatment for uncomplicated type 2 diabetics who fail to meet hemoglobin A1c targets on popular first-line agents such as metformin

Using semaglutide without medical supervision increases the risk of taking an incorrect dose or using a counterfeit or unsafe product

Given that colonic mucosal damage typically initiates at the crypt surface and progresses to the base in response to harmful factors, PYY-positive cells in the superficial layer may be more susceptible to loss compared to GLP-1-positive cells in the basal layer